Investigators Research Group, LLC


Continuous Glucose Monitoring System Study

Age: 4-30

Condition: Type 1 or Type 2 Diabetics that use a self monitoring glucose device to manage their Diabetes.

Study length: 6 months with 2 office visits and 5 phone call visits. 

Provided: Continuous Glucose Monitor System and study related care.  Patient compensation is $455 total if study is completed. 

Insurance is not needed.

Call 317-297-7999 x 3 or click the enroll tab.